Accessibility Menu
Bnb Plus logo

Bnb Plus(NASDAQ) APDN

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-100%
5 Year-100%
1 Year-98%
1 Month-98%
N/A
Bnb Plus last closing stock price
MetricPriceDate
Last closeUSD 0.112026-07-31
Bnb Plus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+26.36%USD 0.092026-07-24
1 month-98.04%USD 5.622025-10-06
3 month-98.04%USD 5.622025-10-06
Year to date-98.04%USD 5.622025-10-06
1 year-97.62%USD 4.632025-07-31
3 year-100%USD 27,900.002023-08-01
5 year-100%USD 80,700.002021-07-30
Since inception-100%USD 89,928,057.552003-04-21

Bnb Plus Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.55M

Net Income (TTM)

-$64.92M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Dec 25, 2025

APDN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bnb Plus

Applied DNA Sciences, Inc. is a biotechnology company specializing in the development and commercialization of DNA and RNA technologies. The company's core areas include the enzymatic production of synthetic DNA for nucleic acid-based therapeutics, molecular diagnostics, and DNA security solutions. With an emphasis on innovative platforms, Applied DNA Sciences aims to capitalize on the growing opportunities in genetic engineering and synthetic biology, prioritizing expansion within the mRNA therapeutics sector. The company is undergoing a strategic review to better align its resources toward its most promising business segments.

Products and Services

Therapeutic DNA Production Services: Provides synthetic DNA and RNA for medical therapeutics.

MDx Testing Services: Offers molecular diagnostics and genetic testing.

DNA Tagging and Security Products: Uses DNA tags for product authenticity and supply chain security.

What Makes Applied DNA Sciences, Inc. Special

Applied DNA Sciences is unique due to its proprietary DNA technology that enhances supply chain integrity and product authenticity across industries such as textiles, pharmaceuticals, and security. This technological edge enables compliance with stringent industry regulations and offers significant competitive advantages.

Five Things You Need to Know

The company emphasizes its LineaDNA platform, which offers a cell-free method for rapid and efficient DNA production.

Strategic focus on increasing presence in the mRNA market, a rapidly growing area in the pharmaceutical industry.

Currently exploring potential divestiture of its DNA Tagging and Security Products and Services segment.

Plans to expand Good Manufacturing Practices (GMP) facilities to enhance production capacities.

Has a strong intellectual property portfolio, with numerous patents across its business segments.

AI Generated • Apr 16, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

26

CEO

Clay D. Shorrock

Website

www.adnas.com

Headquarters

Stony Brook, NY 11790, US

APDN Financials

Key Financial Metrics (TTM)

Gross Margin

43.49%

Operating Margin

-1209.55%

Net Income Margin

-1646.94%

Return on Equity

-337.10%

Return on Capital

-751.62%

Return on Assets

-252.85%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$926.10K

Operating Income

-$35.08M

EBITDA

$6.58M

Operating Cash Flow

-$13.33M

Capital Expenditure

-$10.92K

Free Cash Flow

-$13.34M

Cash & ST Invst.

$949.09K

Total Debt

$0.00

Bnb Plus Performance Analysis

Bnb Plus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 18,168,677101.3%
20232023-09-30USD 13,367,443-26.4%
20242024-09-30USD 2,113,490-84.2%
20252025-09-30USD 2,136,9351.1%
Bnb Plus sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-69.0%
Q42025-09-30-214.1%
Q12025-12-31262.7%
Q22026-03-3181.1%
Bnb Plus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD -14,013.60-54.8%
20232023-09-30USD -11,411.25-18.6%
20242024-09-30USD -1,366.43-88.0%
20252025-09-30USD -134.23-90.2%
Bnb Plus sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-121.5%
Q42025-09-30-148.0%
Q12025-12-3197.5%
Q22026-03-3167.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.02M

+4.1%

Gross Profit

$826.79K

+122.9%

Gross Margin

80.73%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

46

N/A

Net Income

-$6.67M

+75.5%

EBITDA

$20.19K

+100.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$949.09K

-86.1%

Total Debt

$0.00

-100.0%

Accounts Receivable

$303.27K

-56.0%

Inventory

$115.40K

-66.9%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.53%

N/A

Return on Invested Capital

-2.08%

N/A

Free Cash Flow

-$2.05M

+39.2%

Operating Cash Flow

-$2.05M

+35.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARAVAravive, Inc.
$0.04-13.39%
QTTBQ32 Bio Inc.
$15.68+0.77%
NOVNNovan, Inc.
$0.09-24.84%
BPTSBiophytis S.A.
$8.22-13.47%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About APDN

What is the current price of Bnb Plus?

Bnb Plus is trading at N/A per share.

What is the 52-week range for Bnb Plus?

Over the past 52 weeks, Bnb Plus has traded between N/A and N/A.

How much debt does Bnb Plus have?

As of the most recent reporting period, Bnb Plus reported total debt of $0.00.

How much cash does Bnb Plus have on hand?

Bnb Plus reported $949.09K in cash and cash equivalents in its most recent financial results.

What is Bnb Plus’s dividend yield?

Bnb Plus does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services